Mesoblast Announces Retirement of Directors William Burns and Philip Krause

• Mesoblast director William Burns will retire at the 2026 annual general meeting, ending 12 years on the board since 2014.
• Philip Krause will also retire from the board, having served as a director since 2022.
• Jane Bell will become Nomination and Remuneration Committee chair, succeeding Burns; she has been co-chair since April 2026.
• New directors will be recruited with U.S. and global commercial expertise in biotechnology and pharmaceuticals to support commercial growth.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mesoblast Limited published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611011846PRIMZONEFULLFEED9867714) on November 01, 2026, and is solely responsible for the information contained therein.